Association of atrial cardiopathy and residual shunt after patent foramen ovale closure in patients experiencing migraine

被引:0
作者
Gao, Xin [1 ]
Zhang, Xinxin [1 ]
Song, Wei [1 ]
Liu, Yan [1 ]
Guo, Ran [1 ]
Jiang, Yinong [1 ]
机构
[1] Dalian Med Univ, Affiliated Hosp 1, Inst Cardiovasc Dis, Dept Cardiol, 193 United Rd, Dalian 116021, Liaoning, Peoples R China
关键词
Atrial cardiopathy; Patent foramen ovale; Residual shunt; Migraine relief; Outcomes of PFO closure; CHAMBER QUANTIFICATION; TRANSCATHETER CLOSURE; EUROPEAN ASSOCIATION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; FIBRILLATION; PREDICTORS; DISEASE; BURDEN;
D O I
10.1186/s40001-025-02423-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
AimsMigraine is a prevalent and incapacitating condition. The association between patent foramen ovale (PFO) and migraine-type headaches has been extensively documented. In clinical practice, patients may observe residual shunting after PFO closure. Nevertheless, the underlying mechanisms affecting residual shunting after PFO closure remain unclear. Recent studies have identified left atrial abnormalities, specifically atrial cardiopathy, as an independent risk factor for the development of atrial fibrillation (AF), left atrial thrombosis, and subsequent stroke. To that end, the present study aims to investigate the relationship between residual shunt occurrence after PFO closure and atrial cardiopathy.MethodsA retrospective analysis comparing postoperative residual shunts in patients with and without atrial cardiopathy was conducted. The study cohort consisted of 174 patients with severe migraine and confirmed right-to-left shunt (RLS) (grades II-IV) who voluntarily opted for PFO closure between April 1, 2021, and December 31, 2022. Enrolled patients were categorized into two groups: PFO with or without atrial cardiopathy.ResultsA total of 174 migraineurs who underwent PFO closure (PFO with atrial cardiopathy group, n = 20; PFO without atrial cardiopathy group, n = 154) were included. Compared to patients without atrial cardiopathy, those with atrial cardiopathy were older (54.85 +/- 11.86 vs. 43.03 +/- 13.78 years, p = 0.0003), had a higher prevalence of hypertension (30.00% vs. 11.69%, p = 0.0255), and a higher prevalence of diabetes mellitus (10.00% vs. 1.30%, p = 0.0146). Following fully adjusted multivariate logistic analysis, atrial cardiopathy (OR = 0.119; P = 0.046), BMI (OR = 0.875; P = 0.025) and atrial septal aneurysm (OR = 5.465; P = 0.028) were identified as independent predictors for residual right-to-left shunt.ConclusionsThe presence of atrial cardiopathy in patients with severe migraine and PFO was inversely associated with residual shunting following PFO closure.
引用
收藏
页数:7
相关论文
共 25 条
  • [1] Atrial fibrillation and coronary artery disease: An integrative review focusing on therapeutic implications of this relationship
    Batta, Akash
    Hatwal, Juniali
    Batta, Akshey
    Verma, Samman
    Sharma, Yash Paul
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2023, 15 (05): : 229 - 243
  • [2] Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale
    Ben-Assa, Eyal
    Rengifo-Moreno, Pablo
    Al-Bawardy, Rasha
    Kolte, Dhaval
    Cigarroa, Ricardo
    Cruz-Gonzalez, Ignacio
    Sakhuja, Rahul
    Elmariah, Sammy
    Pomerantsev, Eugene
    Vaina, Lucia M.
    Ning, MingMing
    Buonanno, Ferdinando S.
    Hung, Judy W.
    Inglessis, Ignacio
    Palacios, Igor F.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (03) : 293 - 302
  • [3] Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence A Prospective Cohort Study
    Deng, Wenjun
    Yin, Shanye
    McMullin, David
    Inglessis-Azuaje, Ignacio
    Elmariah, Sammy
    Hung, Judy
    Lo, Eng H.
    Palacios, Igor F.
    Buonanno, Ferdinando S.
    Ning, MingMing
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (11) : 717 - +
  • [4] Atrial Cardiopathy and Stroke Prevention
    Elkind, Mitchell S. V.
    [J]. CURRENT CARDIOLOGY REPORTS, 2018, 20 (11)
  • [5] Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging
    Galderisi, Maurizio
    Cosyns, Bernard
    Edvardsen, Thor
    Cardim, Nuno
    Delgado, Victoria
    Di Salvo, Giovanni
    Donal, Erwan
    Sade, Leyla Elif
    Ernande, Laura
    Garbi, Madalina
    Grapsa, Julia
    Hagendorff, Andreas
    Kamp, Otto
    Magne, Julien
    Santoro, Ciro
    Stefanidis, Alexandros
    Lancellotti, Patrizio
    Popescu, Bogdan
    Habib, Gilbert
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2017, 18 (12) : 1301 - 1310
  • [6] Percutaneous PFO Closure with Amplatzer PFO Occluder: Predictors of Residual Shunts at 6 Months Follow-up
    Greutmann, Matthias
    Greutmann-Yantiri, Mehtap
    Kretschmar, Oliver
    Senn, Oliver
    Roffi, Marco
    Jenni, Rolf
    Luescher, Thomas F.
    Eberli, Franz R.
    [J]. CONGENITAL HEART DISEASE, 2009, 4 (04) : 252 - 257
  • [7] Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies
    Jalini, Shirin
    Rajalingam, Rajasumi
    Nisenbaum, Rosane
    Javier, Angelo Dave
    Woo, Anna
    Pikula, Aleksandra
    [J]. NEUROLOGY, 2019, 92 (04) : E288 - E294
  • [8] Risk of Dementia Associated With Atrial Cardiopathy: The ARIC Study
    Johansen, Michelle C.
    Wang, Wendy
    Zhang, Michael
    Knopman, David S.
    Ndumele, Chiadi
    Mosley, Thomas H.
    Selvin, Elizabeth
    Shah, Amil M.
    Solomon, Scott D.
    Gottesman, Rebecca F.
    Chen, Lin Yee
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (16):
  • [9] Recurrent cerebrovascular events in patients after percutaneous closure of patent foramen ovale
    Karagianni, Alexia
    Mandalenakis, Zacharias
    Dellborg, Mikael
    Mirzada, Naqibullah
    Johansson, Magnus Carl
    Eriksson, Peter
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (08)
  • [10] Kavinsky Clifford J, 2022, J Soc Cardiovasc Angiogr Interv, V1, P100039, DOI 10.1016/j.jscai.2022.100039